Market Exclusivity Extensions: How Pharma Protects Drugs Beyond Patents
Explore the complex world of market exclusivity extensions and how pharmaceutical companies use regulatory mechanisms beyond patents to block generic competition.
History of Generic Drugs in the United States: How Cheaper Medicines Became the Norm
Generic drugs now make up over 90% of U.S. prescriptions but cost only 23% of total drug spending. Learn how the Hatch-Waxman Act and FDA regulations turned generics from rare exceptions into the backbone of affordable medicine.
Hatch-Waxman Act: How Federal Law Shapes Generic Drug Approval in the U.S.
The Hatch-Waxman Act created the legal framework for generic drug approval in the U.S., saving billions in healthcare costs. Learn how ANDAs, the Orange Book, and patent challenges make generics possible.